Beth Seidenberg
Westlake Village BioPartners Managing Director
Your Intro Paths to Beth Seidenberg
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Beth Seidenberg on
cblocation
San Francisco, California
investment range
$100k - $25.0m
sweet spot
$10.0m
Beth Seidenberg's Past Investments (33)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Tmunity Therapeutics | Series A | $35M | Apr 2018 | |
| Expansion Therapeutics | Series A | $55.3M (Lead) | Jan 2018 | |
| ARMO BioSciences | Series C | $67M | Aug 2017 | |
| Progyny | Series B | $10M | May 2017 | |
| Progyny | Series B | $14.7M | Jun 2016 | |
| TESARO | Post-IPO Equity | $155M (Lead) | Mar 2016 | |
| ARMO BioSciences | Series C | $50M | Feb 2016 | |
| Flexus Biosciences | Venture Round | $15.2M (Lead) | Mar 2015 | |
| Breathe Technologies | Venture Round | $810K | Jan 2015 | |
| 3-V Biosciences | Series D | $28.5M (Lead) | Dec 2014 |
Beth Seidenberg's Media
No media found for Beth Seidenberg. Add it now.
Your Intro Paths to Beth Seidenberg
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Beth Seidenberg on
cb